{"id":"https://openalex.org/W2525012249","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3122","title":"Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor","display_name":"Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2525012249","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3122","mag":"2525012249"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.3122","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056753534","display_name":"Jitesh P. Jani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Jani","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079710654","display_name":"Elsa G. Barbacci-Tobin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Barbacci","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102775918","display_name":"Samit K. Bhattacharya","orcid":"https://orcid.org/0000-0002-0948-4254","observed_orcids":["https://orcid.org/0000-0002-0948-4254"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Bhattacharya","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026187899","display_name":"Charles Boos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Boos","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Campbell","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109339663","display_name":"T Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Clark","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109504130","display_name":"Kevin G. Coleman","orcid":"https://orcid.org/0009-0009-6445-2931","observed_orcids":["https://orcid.org/0009-0009-6445-2931"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Coleman","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063730368","display_name":"Richard D. Connell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Connell","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029602011","display_name":"T. Cosker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Cosker","raw_affiliation_strings":["Pfizer Global Research & Development, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research & Development, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"3122","last_page":"3122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.578000009059906},{"id":"https://openalex.org/keywords/erbb2","display_name":"ERBB2","score":0.6259999871253967},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.5640000104904175},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7870000004768372},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8389999866485596},{"id":"https://openalex.org/keywords/skbr-3-cells","display_name":"SK-BR-3 cells","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4320000112056732},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6349999904632568},{"id":"https://openalex.org/keywords/her2-positive-cancer","display_name":"HER2-positive cancer","score":0.5339999794960022},{"id":"https://openalex.org/keywords/nonclinical-toxicology","display_name":"nonclinical toxicology","score":0.7990000247955322},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.4740000069141388},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C150109051","wikidata":"https://www.wikidata.org/wiki/Q3630494","display_name":"Autophosphorylation","level":4,"score":0.7685493230819702},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.6562078595161438},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6026015877723694},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.49175193905830383},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.48612499237060547},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46378740668296814},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.442238450050354},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4419286549091339},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.4378669261932373},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4340807795524597},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39279597997665405},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36518779397010803},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33865487575531006},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30144619941711426},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2271592915058136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20542830228805542},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.18384835124015808},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.16679376363754272},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.16120979189872742},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.15329140424728394},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.3122","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.3122","doi":"https://doi.org/10.1200/jco.2004.22.90140.3122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.3122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2082223583","https://openalex.org/W3171898804","https://openalex.org/W2114195503","https://openalex.org/W2245870774","https://openalex.org/W7095400494","https://openalex.org/W2041783977","https://openalex.org/W1591443723","https://openalex.org/W2917981119","https://openalex.org/W2131362842","https://openalex.org/W2336389733"],"abstract_inverted_index":{"3122":[0],"Background:":[1],"The":[2,88],"HER2":[3,23,59,99,116,128,137,149,168,207,275],"(neu/erbB2)":[4],"proto-oncogene":[5],"has":[6,33],"been":[7,34],"linked":[8],"to":[9,40,97,224,255],"human":[10,104,247],"malignancies":[11],"including":[12],"tumors":[13,210,230,243],"of":[14,21,27,44,57,63,66,70,81,107,161,177,202,209,241],"the":[15,22,67,82,162,167,175,239],"breast,":[16],"ovary":[17],"and":[18,25,46,65,101,120,133,141,166,174,198,237,267],"stomach.":[19],"Amplification":[20],"gene":[24],"over-expression":[26],"this":[28],"membrane":[29],"receptor":[30,75,150,159],"tyrosine":[31,60,143],"kinase":[32,129],"implicated":[35],"in":[36,103,152,211,257,263,278],"tumor":[37,105,248],"growth,":[38],"sensitivity":[39],"standard":[41],"chemotherapy,":[42],"prognosis":[43],"patients":[45],"disease":[47],"free":[48],"survival.":[49],"Methods:":[50],"Novel":[51],"compounds":[52],"were":[53],"evaluated":[54,93],"as":[55,244,246],"inhibitors":[56],"recombinant":[58],"kinase-catalyzed":[61],"phosphorylation":[62,100,151],"poly-glu/tyr":[64],"EGF-induced":[68,148],"autophosphorylation":[69,208],"cellular":[71],"epidermal":[72],"growth":[73,102,176,240],"factor":[74],"or":[76,286,289],"a":[77,112,157,199,273],"chimeric":[78,158],"protein":[79],"consisting":[80,160],"EGFR":[83,163],"extracellular":[84,164],"domain/HER2":[85],"intracellular":[86,169],"domain.":[87],"title":[89],"inhibitor":[90,276],"was":[91,118,260],"further":[92,123],"for":[94,122,136],"its":[95],"ability":[96],"reduce":[98],"xenografts":[106],"athymic":[108,225],"mice.":[109],"Results:":[110],"CP-724,714,":[111],"potent,":[113],"orally":[114,190],"active":[115],"inhibitor,":[117],"identified":[119],"characterized":[121],"development.":[124],"This":[125],"compound":[126,192],"inhibits":[127],"(IC50":[130,171,180],"3.8":[131],"ng/ml)":[132,173],"is":[134,188,272],"selective":[135],"vs.":[138],"HER1,":[139],"HER4":[140],"other":[142],"kinases":[144],"examined.":[145],"CP-724714":[146,271],"reduces":[147,206],"NIH":[153],"3T3":[154],"cells":[155,179],"expressing":[156],"domain":[165,170],"15":[172],"SKBr3":[178],"25":[181],"ng/ml).":[182],"Pre-clinical":[183],"findings":[184],"suggest":[185],"that":[186],"CP-724,714":[187,259],"an":[189],"bio-available":[191],"with":[193],"moderate":[194],"clearance":[195],"(11\u201312":[196],"ml/min/kg),":[197],"low":[200],"probability":[201],"drug:drug":[203],"interactions.":[204],"It":[205],"vivo":[212],"(ED50":[213],"\u223c":[214,218],"19":[215],"mg/kg,":[216],"EC50":[217],"980":[219],"ng/ml),":[220],"after":[221],"oral":[222],"administration":[223],"mice":[226],"bearing":[227],"FRE":[228],"erbB2":[229],"(Fisher":[231],"rat":[232],"embryonic":[233],"fibroblasts":[234],"over-expressing":[235],"HER2),":[236],"inhibited":[238],"these":[242],"well":[245],"xenografts.":[249],"In":[250],"nonclinical":[251],"toxicology":[252],"studies":[253],"up":[254],"1-month":[256],"duration,":[258],"relatively":[261],"well-tolerated":[262],"both":[264],"Sprague-Dawley":[265],"rats":[266],"Beagle":[268],"dogs.":[269],"Conclusions:":[270],"novel":[274],"now":[277],"Phase":[279],"I":[280],"clinical":[281],"trials.":[282],"Author":[283],"Disclosure":[284],"Employment":[285],"Leadership":[287],"Consultant":[288],"Advisory":[290],"Stock":[291],"Ownership":[292],"Honoraria":[293],"Research":[294],"Funding":[295],"Expert":[296],"Testimony":[297],"Other":[298],"Remuneration":[299],"Pfizer":[300,301]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-10-07T00:00:00"}